Nonlinear shows its class against big global players
Apr 23 2009 by Andrew Mernin, The Journal
FROM the confines of a nondescript office near the banks of the Tyne, a small team of scientists is taking on the world and winning.
Its 25-strong workforce may only amount to a mere fraction of the armies of white-coated workers on the payroll at its multi-national rivals.
However, Newcastle’s Nonlinear Dynamics has continued to prove that it can go toe-to-toe with global empires like GE and Bio-Rad – which employs 6,500 people worldwide – with the news of two more overseas contract wins.
The company, which develops software for the life sciences industry, has won two deals which will see one of its newest products distributed in Asia and in the US and the ongoing expansion of one of its existing lines.
It has signed a deal with Japanese life sciences and drug development group Shimadzu Biotech to distribute its Progenesis MALDI product across Japan and the US.
The software is used by scientists to analyse data and manage their workflow when they are experimenting in search of biomarkers – a biochemical sign which can be used to measure the progress of a disease or the effects of treatment.
It is also in the process of negotiating a deal with California-headquartered Alpha Innotech which will see a simplified version of one of its flagship products sold globally to teams of researchers working on smaller-scale experiments.
